10x Genomics
322 hedge funds and large institutions have $12.8B invested in 10x Genomics in 2021 Q1 according to their latest regulatory filings, with 78 funds opening new positions, 127 increasing their positions, 87 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
0.67% less ownership
Funds ownership: 82.63% → 81.96% (-0.67%)
18% less call options, than puts
Call options by funds: $33.1M | Put options by funds: $40.3M
Holders
322
Holding in Top 10
10
Calls
$33.1M
Puts
$40.3M
Top Buyers
| 1 | +$513M | |
| 2 | +$160M | |
| 3 | +$156M | |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$145M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$122M |
Top Sellers
| 1 | -$444M | |
| 2 | -$160M | |
| 3 | -$79M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$56.8M |
| 5 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$43.2M |